Serum selenium is low in newly diagnosed Graves' disease: a population-based study

Summary Context Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. Objective To compare serum selenium (s‐Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population. Design and settings S...

Full description

Saved in:
Bibliographic Details
Published inClinical endocrinology (Oxford) Vol. 79; no. 4; pp. 584 - 590
Main Authors Bülow Pedersen, Inge, Knudsen, Nils, Carlé, Allan, Schomburg, Lutz, Köhrle, Josef, Jørgensen, Torben, Rasmussen, Lone Banke, Ovesen, Lars, Laurberg, Peter
Format Journal Article
LanguageEnglish
Published Oxford Blackwell Publishing Ltd 01.10.2013
Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0300-0664
1365-2265
1365-2265
DOI10.1111/cen.12185

Cover

Loading…
Abstract Summary Context Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. Objective To compare serum selenium (s‐Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population. Design and settings S‐Se was measured in triplicate by a fluorimetric method. Participants Patients with newly diagnosed Graves’ disease (GD) (n = 97) or autoimmune overt hypothyroidism (AIH) (n = 96), euthyroid subjects with high serum levels of thyroid peroxidase antibody (TPO‐Ab) (TPO‐Ab > 1500 U/ml, n = 92) and random controls (n = 830). Main outcome measure Differences in s‐Se values. Results S‐Se was lower in patients with GD than in controls (mean (SD), GD: 89·9 μg/l (18·4); controls: 98·8 μg/l (19·7), P < 0·01). This was confirmed in a multivariate logistic regression model adjusting for age, sex, mineral supplements, smoking, geographical region and time of sampling (P < 0·01). In a linear model, s‐Se was similar in patients with AIH (mean (SD): 98·4 μg/l (24·9)) and in controls (P = 0·86). In the multivariate model however, s‐Se was marginally lower in patients with AIH compared to controls (P = 0·04). There was no significant difference in s‐Se between euthyroid participants with high TPO‐Ab and random controls (linear: P = 0·97; multivariate: P = 0·27). Conclusion Patients with newly diagnosed GD and AIH had significantly lower s‐Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune thyroid disease, especially GD.
AbstractList Summary Context Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. Objective To compare serum selenium (s‐Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population. Design and settings S‐Se was measured in triplicate by a fluorimetric method. Participants Patients with newly diagnosed Graves’ disease (GD) (n = 97) or autoimmune overt hypothyroidism (AIH) (n = 96), euthyroid subjects with high serum levels of thyroid peroxidase antibody (TPO‐Ab) (TPO‐Ab > 1500 U/ml, n = 92) and random controls (n = 830). Main outcome measure Differences in s‐Se values. Results S‐Se was lower in patients with GD than in controls (mean (SD), GD: 89·9 μg/l (18·4); controls: 98·8 μg/l (19·7), P < 0·01). This was confirmed in a multivariate logistic regression model adjusting for age, sex, mineral supplements, smoking, geographical region and time of sampling (P < 0·01). In a linear model, s‐Se was similar in patients with AIH (mean (SD): 98·4 μg/l (24·9)) and in controls (P = 0·86). In the multivariate model however, s‐Se was marginally lower in patients with AIH compared to controls (P = 0·04). There was no significant difference in s‐Se between euthyroid participants with high TPO‐Ab and random controls (linear: P = 0·97; multivariate: P = 0·27). Conclusion Patients with newly diagnosed GD and AIH had significantly lower s‐Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune thyroid disease, especially GD.
Summary Context Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. Objective To compare serum selenium (s-Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population. Design and settings S-Se was measured in triplicate by a fluorimetric method. Participants Patients with newly diagnosed Graves' disease (GD) (n = 97) or autoimmune overt hypothyroidism (AIH) (n = 96), euthyroid subjects with high serum levels of thyroid peroxidase antibody (TPO-Ab) (TPO-Ab > 1500 U/ml, n = 92) and random controls (n = 830). Main outcome measure Differences in s-Se values. Results S-Se was lower in patients with GD than in controls (mean (SD), GD: 89·9 µg/l (18·4); controls: 98·8 µg/l (19·7), P < 0·01). This was confirmed in a multivariate logistic regression model adjusting for age, sex, mineral supplements, smoking, geographical region and time of sampling (P < 0·01). In a linear model, s-Se was similar in patients with AIH (mean (SD): 98·4 µg/l (24·9)) and in controls (P = 0·86). In the multivariate model however, s-Se was marginally lower in patients with AIH compared to controls (P = 0·04). There was no significant difference in s-Se between euthyroid participants with high TPO-Ab and random controls (linear: P = 0·97; multivariate: P = 0·27). Conclusion Patients with newly diagnosed GD and AIH had significantly lower s-Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune thyroid disease, especially GD. [PUBLICATION ABSTRACT]
Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. To compare serum selenium (s-Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population. S-Se was measured in triplicate by a fluorimetric method. Patients with newly diagnosed Graves' disease (GD) (n = 97) or autoimmune overt hypothyroidism (AIH) (n = 96), euthyroid subjects with high serum levels of thyroid peroxidase antibody (TPO-Ab) (TPO-Ab > 1500 U/ml, n = 92) and random controls (n = 830). Differences in s-Se values. S-Se was lower in patients with GD than in controls (mean (SD), GD: 89·9 μg/l (18·4); controls: 98·8 μg/l (19·7), P < 0·01). This was confirmed in a multivariate logistic regression model adjusting for age, sex, mineral supplements, smoking, geographical region and time of sampling (P < 0·01). In a linear model, s-Se was similar in patients with AIH (mean (SD): 98·4 μg/l (24·9)) and in controls (P = 0·86). In the multivariate model however, s-Se was marginally lower in patients with AIH compared to controls (P = 0·04). There was no significant difference in s-Se between euthyroid participants with high TPO-Ab and random controls (linear: P = 0·97; multivariate: P = 0·27). Patients with newly diagnosed GD and AIH had significantly lower s-Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune thyroid disease, especially GD.
Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease.CONTEXTSelenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease.To compare serum selenium (s-Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population.OBJECTIVETo compare serum selenium (s-Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population.S-Se was measured in triplicate by a fluorimetric method.DESIGN AND SETTINGSS-Se was measured in triplicate by a fluorimetric method.Patients with newly diagnosed Graves' disease (GD) (n = 97) or autoimmune overt hypothyroidism (AIH) (n = 96), euthyroid subjects with high serum levels of thyroid peroxidase antibody (TPO-Ab) (TPO-Ab > 1500 U/ml, n = 92) and random controls (n = 830).PARTICIPANTSPatients with newly diagnosed Graves' disease (GD) (n = 97) or autoimmune overt hypothyroidism (AIH) (n = 96), euthyroid subjects with high serum levels of thyroid peroxidase antibody (TPO-Ab) (TPO-Ab > 1500 U/ml, n = 92) and random controls (n = 830).Differences in s-Se values.MAIN OUTCOME MEASUREDifferences in s-Se values.S-Se was lower in patients with GD than in controls (mean (SD), GD: 89·9 μg/l (18·4); controls: 98·8 μg/l (19·7), P < 0·01). This was confirmed in a multivariate logistic regression model adjusting for age, sex, mineral supplements, smoking, geographical region and time of sampling (P < 0·01). In a linear model, s-Se was similar in patients with AIH (mean (SD): 98·4 μg/l (24·9)) and in controls (P = 0·86). In the multivariate model however, s-Se was marginally lower in patients with AIH compared to controls (P = 0·04). There was no significant difference in s-Se between euthyroid participants with high TPO-Ab and random controls (linear: P = 0·97; multivariate: P = 0·27).RESULTSS-Se was lower in patients with GD than in controls (mean (SD), GD: 89·9 μg/l (18·4); controls: 98·8 μg/l (19·7), P < 0·01). This was confirmed in a multivariate logistic regression model adjusting for age, sex, mineral supplements, smoking, geographical region and time of sampling (P < 0·01). In a linear model, s-Se was similar in patients with AIH (mean (SD): 98·4 μg/l (24·9)) and in controls (P = 0·86). In the multivariate model however, s-Se was marginally lower in patients with AIH compared to controls (P = 0·04). There was no significant difference in s-Se between euthyroid participants with high TPO-Ab and random controls (linear: P = 0·97; multivariate: P = 0·27).Patients with newly diagnosed GD and AIH had significantly lower s-Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune thyroid disease, especially GD.CONCLUSIONPatients with newly diagnosed GD and AIH had significantly lower s-Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune thyroid disease, especially GD.
Author Schomburg, Lutz
Köhrle, Josef
Rasmussen, Lone Banke
Carlé, Allan
Laurberg, Peter
Jørgensen, Torben
Ovesen, Lars
Bülow Pedersen, Inge
Knudsen, Nils
Author_xml – sequence: 1
  givenname: Inge
  surname: Bülow Pedersen
  fullname: Bülow Pedersen, Inge
  email: I.Bulow@rn.dk
  organization: Department of Endocrinology and Medicine, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
– sequence: 2
  givenname: Nils
  surname: Knudsen
  fullname: Knudsen, Nils
  organization: Endocrine Unit, Medical Clinic I, Bispebjerg Hospital, Copenhagen, Denmark
– sequence: 3
  givenname: Allan
  surname: Carlé
  fullname: Carlé, Allan
  organization: Department of Endocrinology and Medicine, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
– sequence: 4
  givenname: Lutz
  surname: Schomburg
  fullname: Schomburg, Lutz
  organization: Institute for Experimental Endocrinology, Charité-Universitätsmedizin, Berlin, Germany
– sequence: 5
  givenname: Josef
  surname: Köhrle
  fullname: Köhrle, Josef
  organization: Institute for Experimental Endocrinology, Charité-Universitätsmedizin, Berlin, Germany
– sequence: 6
  givenname: Torben
  surname: Jørgensen
  fullname: Jørgensen, Torben
  organization: Research Centre for Prevention and Health, Glostrup Hospital, Glostrup, Denmark
– sequence: 7
  givenname: Lone Banke
  surname: Rasmussen
  fullname: Rasmussen, Lone Banke
  organization: Department of Nutrition, National Food Institute, Technical University of Denmark, Søborg, Denmark
– sequence: 8
  givenname: Lars
  surname: Ovesen
  fullname: Ovesen, Lars
  organization: Department of Internal Medicine, Slagelse Hospital, Slagelse, Denmark
– sequence: 9
  givenname: Peter
  surname: Laurberg
  fullname: Laurberg, Peter
  organization: Department of Endocrinology and Medicine, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27697084$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23448365$$D View this record in MEDLINE/PubMed
BookMark eNpd0U1PGzEQBmALUZVAe-gfQCuhqlwW_L12b1UESVEEEm1p1Ytl706QwfGm62xD_j0OCSDhi0f2MyPL7z7ajW0EhD4RfELyOq0hnhBKlNhBA8KkKCmVYhcNMMO4xFLyPbSf0h3GWChcvUd7lHGuMhyg6x_Q9bMiQYDoc-FTEdpl4WMRYRlWRePtbWwTNMWos_8hfcknCWyCr4Ut5u28D3bh21g6uzZp0TerD-jd1IYEH7f7Afp1fvZzOC4nV6Pvw2-T0nPCRMmZ49xVimjOBW2IdJhiR6kG4qZOKadorWvJtQKuKWEUhBO1FqIRuiE1YwfoeDN33rX_ekgLM_OphhBshLZPhnCGlcQE80yP3tC7tu9ifp0hgmpRYcV1Vodb1bsZNGbe-ZntVub5tzL4vAU21TZMOxtrn15dJfV6UnanG7f0AVYv9wSbdVwmx2We4jLDs8unIneUmw6fFvDw0mG7eyMrVgnz-3Jk_k7GFxd_rm_MmD0C1SKVKA
CODEN CLECAP
ContentType Journal Article
Copyright 2013 John Wiley & Sons Ltd
2014 INIST-CNRS
2013 John Wiley & Sons Ltd.
Copyright © 2013 John Wiley & Sons Ltd
Copyright_xml – notice: 2013 John Wiley & Sons Ltd
– notice: 2014 INIST-CNRS
– notice: 2013 John Wiley & Sons Ltd.
– notice: Copyright © 2013 John Wiley & Sons Ltd
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
NAPCQ
7X8
DOI 10.1111/cen.12185
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList
ProQuest Health & Medical Complete (Alumni)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2265
EndPage 590
ExternalDocumentID 3317546361
23448365
27697084
CEN12185
ark_67375_WNG_ZLHJJXRV_H
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Denmark
GeographicLocations_xml – name: Denmark
GrantInformation_xml – fundername: Danish Medical Foundation
– fundername: Tømmerhandler Wilhelm Bangs Foundation
– fundername: The German Research Foundation
– fundername: The German Cancer Aid
– fundername: North Jutland County Research Foundation
– fundername: 1991 Pharmacy Foundation
– fundername: Copenhagen Hospital Corporation Research Foundation
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
08P
0R~
10A
1OB
1OC
29B
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AAQQT
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
REN
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAMMB
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-i4135-43b44b78194452d16b020b229e1bfb88b82c9c6498e492132e5b5c955d59d1c33
IEDL.DBID DR2
ISSN 0300-0664
1365-2265
IngestDate Tue Aug 05 11:36:45 EDT 2025
Wed Aug 13 11:22:24 EDT 2025
Mon Jul 21 06:04:54 EDT 2025
Mon Jul 21 09:14:00 EDT 2025
Wed Jan 22 16:51:31 EST 2025
Wed Oct 30 09:57:01 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Endocrinopathy
Immunopathology
Hyperthyroidism
Thyroid diseases
Graves disease
Autoimmune disease
Early stage
Serum
Selenium
Statistical study
Endocrinology
Language English
License CC BY 4.0
2013 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-i4135-43b44b78194452d16b020b229e1bfb88b82c9c6498e492132e5b5c955d59d1c33
Notes Copenhagen Hospital Corporation Research Foundation
Danish Medical Foundation
North Jutland County Research Foundation
The German Cancer Aid
istex:600C1E0D90DDE1A9D9012D22FE113E8A0978C30E
Tømmerhandler Wilhelm Bangs Foundation
ArticleID:CEN12185
The German Research Foundation
1991 Pharmacy Foundation
ark:/67375/WNG-ZLHJJXRV-H
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 23448365
PQID 1529570849
PQPubID 36523
PageCount 7
ParticipantIDs proquest_miscellaneous_1430860104
proquest_journals_1529570849
pubmed_primary_23448365
pascalfrancis_primary_27697084
wiley_primary_10_1111_cen_12185_CEN12185
istex_primary_ark_67375_WNG_ZLHJJXRV_H
PublicationCentury 2000
PublicationDate October 2013
PublicationDateYYYYMMDD 2013-10-01
PublicationDate_xml – month: 10
  year: 2013
  text: October 2013
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Clinical endocrinology (Oxford)
PublicationTitleAlternate Clin Endocrinol
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Blackwell
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
– name: Wiley Subscription Services, Inc
References Carle, A., Pedersen, I.B., Knudsen, N. et al. (2011) Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. European Journal of Endocrinology, 164, 801-809.
Vrca, V.B., Skreb, F., Cepelak, I. et al. (2004) Supplementation with antioxidants in the treatment of Graves′ disease; the effect on glutathione peroxidase activity and concentration of selenium. Clinica Chimica Acta, 341, 55-63.
Toulis, K.A., Anastasilakis, A.D., Tzellos, T.G. et al. (2010) Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid, 20, 163-1173.
Broome, C.S., McArdle, F., Kyle, J.A. et al. (2004) An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. The American Journal of Clinical Nutrition, 80, 154-162.
Carle, A., Laurberg, P., Pedersen, I.B. et al. (2006) Epidemiology of subtypes of hypothyroidism in Denmark. European Journal of Endocrinology, 154, 21-28.
Duntas, L.H. (2008) Environmental factors and autoimmune thyroiditis. Nature Clinical Practice Endocrinology & Metabolism, 4, 454-460.
Schomburg, L., Schweizer, U., Holtmann, B. et al. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochemical Journal, 370, 397-402.
Stoedter, M., Renko, K., Hog, A. et al. (2010) Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice. Biochemical Journal, 429, 43-51.
Chiu-Ugalde, J., Wirth, E.K., Klein, M.O. et al. (2012) Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxidants & Redox Signaling, 17, 902-913.
Nacamulli, D., Mian, C., Petricca, D. et al. (2010) Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clinical Endocrinology, 73, 535-539.
Bulow Pedersen, I., Knudsen, N., Jorgensen, T. et al. (2002) Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. The Journal of Clinical Endocrinology & Metabolism, 87, 4462-4469.
Nichol, C., Herdman, J., Sattar, N. et al. (1998) Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? Clinical Chemistry, 44, 1764-1766.
Rasmussen, L.B., Schomburg, L., Kohrle, J. et al. (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. European Journal of Endocrinology, 164, 585-590.
Pedersen, O.M., Aardal, N.P., Larssen, T.B. et al. (2000) The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid, 10, 251-259.
Duntas, L.H. (2010) Selenium and the thyroid: a close-knit connection. Journal of Clinical Endocrinology & Metabolism, 95, 5180-5188.
Pedersen, I.B., Knudsen, N., Jorgensen, T. et al. (2003) Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clinical Endocrinology, 58, 36-42.
Duntas, L.H., Mantzou, E. & Koutras, D.A. (2003) Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology, 148, 389-393.
Rayman, M.P. (2000) The importance of selenium to human health. The Lancet, 356, 233-241.
Schomburg, L. & Schweizer, U. (2009) Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochimica et Biophysica Acta, 1790, 1453-1462.
Derumeaux, H., Valeix, P., Castetbon, K. et al. (2003) Association of selenium with thyroid volume and echostructure in 35 to 60-year-old French adults. European Journal of Endocrinology, 148, 309-315.
Köhrle, J. & Gartner, R. (2009) Selenium and thyroid. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 815-827.
Bonfig, W., Gartner, R. & Schmidt, H. (2010) Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. The Scientific World Journal, 10, 990-996.
Burch, H.B., Lahiri, S., Bahn, R.S. et al. (1997) Superoxide radical production stimulates retroocular fibroblast proliferation in Graves′ ophthalmopathy. Experimental Eye Research, 65, 311-316.
Raber, W., Gessl, A., Nowotny, P. et al. (2002) Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid, 2, 725-731.
Karanikas, G., Schuetz, M., Kontur, S. et al. (2008) No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 18, 7-12.
Contempre, B., Dumont, J.E., Denef, J.F. et al. (1995) Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. European Journal of Endocrinology, 133, 99-109.
Schomburg, L. (2011) Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nature Reviews Endocrinology, 8, 160-171.
Mazokopakis, E.E., Papadakis, J.A., Papadomanolaki, M.G. et al. (2007) Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid, 17, 609-612.
Bulow Pedersen, I., Knudsen, N., Carle, A. et al. (2011) A cautious iodization program bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clinical Endocrinology, 75, 120-126.
Gartner, R. & Gasnier, B.C. (2003) Selenium in the treatment of autoimmune thyroiditis. BioFactors, 19, 165-170.
Liu, C., Papewalis, C., Domberg, J. et al. (2008) Chemokines and autoimmune thyroid disease. Hormones and Metabolic Research, 40, 361-368.
Mittag, J., Behrends, T., Hoefig, C.S. et al. (2010) Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS ONE 5, e12931. www.plosone.org
Kucharzewski, M., Braziewicz, J., Majewska, U. et al. (2002) Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biological Trace Element Research, 88, 25-30.
Negro, R., Greco, G., Mangieri, T. et al. (2007) The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. The Journal of Clinical Endocrinology & Metabolism, 92, 1263-1268.
Prummel, M.F., Strieder, T. & Wiersinga, W.M. (2004) The environment and autoimmune thyroid diseases. European Journal of Endocrinology, 150, 605-618.
Gartner, R., Gasnier, B.C., Dietrich, J.W. et al. (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. The Journal of Clinical Endocrinology & Metabolism, 87, 1687-1691.
Laclaustra, M., Navas-Acien, A., Stranges, S. et al. (2009) Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environmental Health Perspectives, 117, 1409-1413.
Marcocci, C., Kahaly, G.J., Krassas, G.E. et al. (2011) Selenium and the course of mild Graves′ orbitopathy. The New England Journal of Medicine, 364, 1920-1931.
Rasmussen, L.B., Hollenbach, B., Laurberg, P. et al. (2009) Serum selenium and selenoprotein P status in adult Danes 8-year follow-up. Journal of Trace Elements in Medicine & Biology, 23, 265-271.
Sheck, L. (2011) Selenium and the course of mild Graves′ orbitopathy. The New England Journal of Medicine, 365, 770-771.
Kryukov, G.V., Castellano, S., Novoselov, S.V. et al. (2003) Characterization of mammalian selenoproteomes. Science, 300, 1439-1443.
Krysiak, R. & Okopien, B. (2011) The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. The Journal of Clinical Endocrinology & Metabolism, 96, 2206-2215.
2009; 23
2007; 17
2004; 341
2010; 10
2010; 429
1997; 65
2000; 356
2008; 18
2011; 75
2003; 58
2003; 370
2002; 2
2011; 96
2006; 154
2007; 92
2012; 17
1995; 133
2003; 19
2008; 4
2011; 8
1998; 44
2009; 117
2010; 20
2000; 10
2004; 150
2002; 87
2002; 88
2003; 148
2008; 40
2009; 1790
2004; 80
2003; 300
2010; 5
2011; 365
2010; 73
2011; 364
2010; 95
2011; 164
References_xml – reference: Köhrle, J. & Gartner, R. (2009) Selenium and thyroid. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 815-827.
– reference: Schomburg, L. (2011) Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nature Reviews Endocrinology, 8, 160-171.
– reference: Negro, R., Greco, G., Mangieri, T. et al. (2007) The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. The Journal of Clinical Endocrinology & Metabolism, 92, 1263-1268.
– reference: Raber, W., Gessl, A., Nowotny, P. et al. (2002) Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid, 2, 725-731.
– reference: Kryukov, G.V., Castellano, S., Novoselov, S.V. et al. (2003) Characterization of mammalian selenoproteomes. Science, 300, 1439-1443.
– reference: Krysiak, R. & Okopien, B. (2011) The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. The Journal of Clinical Endocrinology & Metabolism, 96, 2206-2215.
– reference: Prummel, M.F., Strieder, T. & Wiersinga, W.M. (2004) The environment and autoimmune thyroid diseases. European Journal of Endocrinology, 150, 605-618.
– reference: Pedersen, I.B., Knudsen, N., Jorgensen, T. et al. (2003) Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clinical Endocrinology, 58, 36-42.
– reference: Gartner, R., Gasnier, B.C., Dietrich, J.W. et al. (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. The Journal of Clinical Endocrinology & Metabolism, 87, 1687-1691.
– reference: Burch, H.B., Lahiri, S., Bahn, R.S. et al. (1997) Superoxide radical production stimulates retroocular fibroblast proliferation in Graves′ ophthalmopathy. Experimental Eye Research, 65, 311-316.
– reference: Laclaustra, M., Navas-Acien, A., Stranges, S. et al. (2009) Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environmental Health Perspectives, 117, 1409-1413.
– reference: Contempre, B., Dumont, J.E., Denef, J.F. et al. (1995) Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. European Journal of Endocrinology, 133, 99-109.
– reference: Schomburg, L., Schweizer, U., Holtmann, B. et al. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochemical Journal, 370, 397-402.
– reference: Liu, C., Papewalis, C., Domberg, J. et al. (2008) Chemokines and autoimmune thyroid disease. Hormones and Metabolic Research, 40, 361-368.
– reference: Duntas, L.H. (2010) Selenium and the thyroid: a close-knit connection. Journal of Clinical Endocrinology & Metabolism, 95, 5180-5188.
– reference: Bulow Pedersen, I., Knudsen, N., Carle, A. et al. (2011) A cautious iodization program bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clinical Endocrinology, 75, 120-126.
– reference: Rayman, M.P. (2000) The importance of selenium to human health. The Lancet, 356, 233-241.
– reference: Nichol, C., Herdman, J., Sattar, N. et al. (1998) Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? Clinical Chemistry, 44, 1764-1766.
– reference: Nacamulli, D., Mian, C., Petricca, D. et al. (2010) Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clinical Endocrinology, 73, 535-539.
– reference: Vrca, V.B., Skreb, F., Cepelak, I. et al. (2004) Supplementation with antioxidants in the treatment of Graves′ disease; the effect on glutathione peroxidase activity and concentration of selenium. Clinica Chimica Acta, 341, 55-63.
– reference: Bonfig, W., Gartner, R. & Schmidt, H. (2010) Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. The Scientific World Journal, 10, 990-996.
– reference: Derumeaux, H., Valeix, P., Castetbon, K. et al. (2003) Association of selenium with thyroid volume and echostructure in 35 to 60-year-old French adults. European Journal of Endocrinology, 148, 309-315.
– reference: Bulow Pedersen, I., Knudsen, N., Jorgensen, T. et al. (2002) Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. The Journal of Clinical Endocrinology & Metabolism, 87, 4462-4469.
– reference: Toulis, K.A., Anastasilakis, A.D., Tzellos, T.G. et al. (2010) Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid, 20, 163-1173.
– reference: Karanikas, G., Schuetz, M., Kontur, S. et al. (2008) No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 18, 7-12.
– reference: Chiu-Ugalde, J., Wirth, E.K., Klein, M.O. et al. (2012) Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxidants & Redox Signaling, 17, 902-913.
– reference: Pedersen, O.M., Aardal, N.P., Larssen, T.B. et al. (2000) The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid, 10, 251-259.
– reference: Schomburg, L. & Schweizer, U. (2009) Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochimica et Biophysica Acta, 1790, 1453-1462.
– reference: Rasmussen, L.B., Schomburg, L., Kohrle, J. et al. (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. European Journal of Endocrinology, 164, 585-590.
– reference: Marcocci, C., Kahaly, G.J., Krassas, G.E. et al. (2011) Selenium and the course of mild Graves′ orbitopathy. The New England Journal of Medicine, 364, 1920-1931.
– reference: Gartner, R. & Gasnier, B.C. (2003) Selenium in the treatment of autoimmune thyroiditis. BioFactors, 19, 165-170.
– reference: Mittag, J., Behrends, T., Hoefig, C.S. et al. (2010) Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS ONE 5, e12931. www.plosone.org
– reference: Broome, C.S., McArdle, F., Kyle, J.A. et al. (2004) An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. The American Journal of Clinical Nutrition, 80, 154-162.
– reference: Stoedter, M., Renko, K., Hog, A. et al. (2010) Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice. Biochemical Journal, 429, 43-51.
– reference: Carle, A., Pedersen, I.B., Knudsen, N. et al. (2011) Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. European Journal of Endocrinology, 164, 801-809.
– reference: Mazokopakis, E.E., Papadakis, J.A., Papadomanolaki, M.G. et al. (2007) Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid, 17, 609-612.
– reference: Sheck, L. (2011) Selenium and the course of mild Graves′ orbitopathy. The New England Journal of Medicine, 365, 770-771.
– reference: Carle, A., Laurberg, P., Pedersen, I.B. et al. (2006) Epidemiology of subtypes of hypothyroidism in Denmark. European Journal of Endocrinology, 154, 21-28.
– reference: Kucharzewski, M., Braziewicz, J., Majewska, U. et al. (2002) Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biological Trace Element Research, 88, 25-30.
– reference: Rasmussen, L.B., Hollenbach, B., Laurberg, P. et al. (2009) Serum selenium and selenoprotein P status in adult Danes 8-year follow-up. Journal of Trace Elements in Medicine & Biology, 23, 265-271.
– reference: Duntas, L.H., Mantzou, E. & Koutras, D.A. (2003) Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology, 148, 389-393.
– reference: Duntas, L.H. (2008) Environmental factors and autoimmune thyroiditis. Nature Clinical Practice Endocrinology & Metabolism, 4, 454-460.
– volume: 364
  start-page: 1920
  year: 2011
  end-page: 1931
  article-title: Selenium and the course of mild Graves′ orbitopathy
  publication-title: The New England Journal of Medicine
– volume: 23
  start-page: 265
  year: 2009
  end-page: 271
  article-title: Serum selenium and selenoprotein P status in adult Danes 8‐year follow‐up
  publication-title: Journal of Trace Elements in Medicine & Biology
– volume: 75
  start-page: 120
  year: 2011
  end-page: 126
  article-title: A cautious iodization program bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population
  publication-title: Clinical Endocrinology
– volume: 40
  start-page: 361
  year: 2008
  end-page: 368
  article-title: Chemokines and autoimmune thyroid disease
  publication-title: Hormones and Metabolic Research
– volume: 8
  start-page: 160
  year: 2011
  end-page: 171
  article-title: Selenium, selenoproteins and the thyroid gland: interactions in health and disease
  publication-title: Nature Reviews Endocrinology
– volume: 150
  start-page: 605
  year: 2004
  end-page: 618
  article-title: The environment and autoimmune thyroid diseases
  publication-title: European Journal of Endocrinology
– volume: 429
  start-page: 43
  year: 2010
  end-page: 51
  article-title: Selenium controls the sex‐specific immune response and selenoprotein expression during the acute‐phase response in mice
  publication-title: Biochemical Journal
– volume: 73
  start-page: 535
  year: 2010
  end-page: 539
  article-title: Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis
  publication-title: Clinical Endocrinology
– volume: 80
  start-page: 154
  year: 2004
  end-page: 162
  article-title: An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status
  publication-title: The American Journal of Clinical Nutrition
– volume: 87
  start-page: 4462
  year: 2002
  end-page: 4469
  article-title: Large differences in incidences of overt hyper‐ and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register‐based population survey
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 10
  start-page: 990
  year: 2010
  end-page: 996
  article-title: Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis
  publication-title: The Scientific World Journal
– volume: 23
  start-page: 815
  year: 2009
  end-page: 827
  article-title: Selenium and thyroid
  publication-title: Best Practice & Research Clinical Endocrinology & Metabolism
– volume: 18
  start-page: 7
  year: 2008
  end-page: 12
  article-title: No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis
  publication-title: Thyroid
– volume: 2
  start-page: 725
  year: 2002
  end-page: 731
  article-title: Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty‐one subjects
  publication-title: Thyroid
– volume: 5
  start-page: e12931
  year: 2010
  article-title: Thyroid hormones regulate selenoprotein expression and selenium status in mice
  publication-title: PLoS ONE
– volume: 92
  start-page: 1263
  year: 2007
  end-page: 1268
  article-title: The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 356
  start-page: 233
  year: 2000
  end-page: 241
  article-title: The importance of selenium to human health
  publication-title: The Lancet
– volume: 87
  start-page: 1687
  year: 2002
  end-page: 1691
  article-title: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 300
  start-page: 1439
  year: 2003
  end-page: 1443
  article-title: Characterization of mammalian selenoproteomes
  publication-title: Science
– volume: 96
  start-page: 2206
  year: 2011
  end-page: 2215
  article-title: The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 19
  start-page: 165
  year: 2003
  end-page: 170
  article-title: Selenium in the treatment of autoimmune thyroiditis
  publication-title: BioFactors
– volume: 65
  start-page: 311
  year: 1997
  end-page: 316
  article-title: Superoxide radical production stimulates retroocular fibroblast proliferation in Graves′ ophthalmopathy
  publication-title: Experimental Eye Research
– volume: 370
  start-page: 397
  year: 2003
  end-page: 402
  article-title: Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues
  publication-title: Biochemical Journal
– volume: 164
  start-page: 585
  year: 2011
  end-page: 590
  article-title: Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency
  publication-title: European Journal of Endocrinology
– volume: 20
  start-page: 163
  year: 2010
  end-page: 1173
  article-title: Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis
  publication-title: Thyroid
– volume: 117
  start-page: 1409
  year: 2009
  end-page: 1413
  article-title: Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004
  publication-title: Environmental Health Perspectives
– volume: 154
  start-page: 21
  year: 2006
  end-page: 28
  article-title: Epidemiology of subtypes of hypothyroidism in Denmark
  publication-title: European Journal of Endocrinology
– volume: 95
  start-page: 5180
  year: 2010
  end-page: 5188
  article-title: Selenium and the thyroid: a close‐knit connection
  publication-title: Journal of Clinical Endocrinology & Metabolism
– volume: 164
  start-page: 801
  year: 2011
  end-page: 809
  article-title: Epidemiology of subtypes of hyperthyroidism in Denmark: a population‐based study
  publication-title: European Journal of Endocrinology
– volume: 10
  start-page: 251
  year: 2000
  end-page: 259
  article-title: The value of ultrasonography in predicting autoimmune thyroid disease
  publication-title: Thyroid
– volume: 1790
  start-page: 1453
  year: 2009
  end-page: 1462
  article-title: Hierarchical regulation of selenoprotein expression and sex‐specific effects of selenium
  publication-title: Biochimica et Biophysica Acta
– volume: 44
  start-page: 1764
  year: 1998
  end-page: 1766
  article-title: Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response?
  publication-title: Clinical Chemistry
– volume: 365
  start-page: 770
  year: 2011
  end-page: 771
  article-title: Selenium and the course of mild Graves′ orbitopathy
  publication-title: The New England Journal of Medicine
– volume: 133
  start-page: 99
  year: 1995
  end-page: 109
  article-title: Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism
  publication-title: European Journal of Endocrinology
– volume: 88
  start-page: 25
  year: 2002
  end-page: 30
  article-title: Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases
  publication-title: Biological Trace Element Research
– volume: 148
  start-page: 309
  year: 2003
  end-page: 315
  article-title: Association of selenium with thyroid volume and echostructure in 35 to 60‐year‐old French adults
  publication-title: European Journal of Endocrinology
– volume: 17
  start-page: 609
  year: 2007
  end-page: 612
  article-title: Effects of 12 months treatment with L‐selenomethionine on serum anti‐TPO Levels in Patients with Hashimoto's thyroiditis
  publication-title: Thyroid
– volume: 341
  start-page: 55
  year: 2004
  end-page: 63
  article-title: Supplementation with antioxidants in the treatment of Graves′ disease; the effect on glutathione peroxidase activity and concentration of selenium
  publication-title: Clinica Chimica Acta
– volume: 58
  start-page: 36
  year: 2003
  end-page: 42
  article-title: Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency
  publication-title: Clinical Endocrinology
– volume: 17
  start-page: 902
  year: 2012
  end-page: 913
  article-title: Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells
  publication-title: Antioxidants & Redox Signaling
– volume: 148
  start-page: 389
  year: 2003
  end-page: 393
  article-title: Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis
  publication-title: European Journal of Endocrinology
– volume: 4
  start-page: 454
  year: 2008
  end-page: 460
  article-title: Environmental factors and autoimmune thyroiditis
  publication-title: Nature Clinical Practice Endocrinology & Metabolism
SSID ssj0005807
Score 2.3807137
Snippet Summary Context Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. Objective To compare serum...
Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. To compare serum selenium (s-Se) values in...
Summary Context Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease. Objective To compare serum...
Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease.CONTEXTSelenium deficiency may play an important...
SourceID proquest
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 584
SubjectTerms Adult
Biological and medical sciences
Denmark
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Graves Disease - blood
Graves Disease - diagnosis
Hashimoto Disease - blood
Hashimoto Disease - diagnosis
Humans
Logistic Models
Male
Medical sciences
Middle Aged
Multivariate Analysis
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Population Surveillance - methods
Selenium - blood
Thyroid Hormones - blood
Thyroid. Thyroid axis (diseases)
Thyroiditis, Autoimmune
Vertebrates: endocrinology
Title Serum selenium is low in newly diagnosed Graves' disease: a population-based study
URI https://api.istex.fr/ark:/67375/WNG-ZLHJJXRV-H/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcen.12185
https://www.ncbi.nlm.nih.gov/pubmed/23448365
https://www.proquest.com/docview/1529570849
https://www.proquest.com/docview/1430860104
Volume 79
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CDqGXtunTbRpUKKUXh7UsyVZ6KiHJsjR7CE26lIKRZBmWpN4Q75Kkp_yEXvv38ks6I3udpvRQehPoga2Zkb7RvADeWDeQpR6YuEIsGgufqdgmmYtzPAmNycpkYOm942CshkdiNJGTFXi_jIVp80P0D24kGeG8JgE3tvlNyJ2vKTVCTgHm5KtFgOjwNnWU7EKlU4qcVkp0WYXIi6efiYCU9vKSHCJNg3tStcUs_oY274LXcPvsPYCvy-9unU5OthZzu-W-_5HS8T9_7CHc71Ap-9Cy0Tqs-PoRrB10dvfHcIxHyuIbo8pM9RQb04adzi7YtGaIyk-vWNk67PmS7VM5o-bm-ifrTD_bzLCzvkrYzfUPujdLFtLaPoGjvd1PO8O4q8gQT_GyQ1qmVgibIYoQQvIyURbRpuVc-8RWNs9tzp12SujcC81R0fXSSqelLKUuE5emT2G1ntX-OTBuEXtJj_qa9cJpYyvpbcVTnKi0MlkEbwNtirM260Zhzk_ICS2TxefxfvHl43A0mhweF8MINu8Qr5_AM6WzQS4i2FhSs-gEtCkSMnBSr47gdd-NokX2ElP72QLHiBQVPlJYI3jWcsHt4inqtch1EbwLtOw7lkoVUrEIVCx2dseh8eLfh76Ee5zKbgSnwQ1YnZ8v_CsEP3O7Gbj8FwbG_4s
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEX3tBAKUZCiEuqTWI7MeKCqrZh2d1D1ZYVErLsxJFWbbNVd1c8Tv0JXPl7_SXMONmUIg6ImyU_lHg89jee8TcAL23RE6XqmbBCLBpyl8rQRmkRZrgTGpOWUc_SfcdwJPMD3h-L8Qq8Xb6Fafghugs30gy_X5OC04X0b1peuJq4ETJxDa5TRm9vUO1dkkeJ9rF0Qm-npeQtrxDF8XRdEZLSbH6lkEgzw1mpmnQWf8ObV-GrP3927sDn5Zc3YSdHm4u53Sy-_0Hq-L-_dhdut8CUvWtW0j1YcfV9uDFsXe8P4BB3lcUJo-RM9QQLkxk7nn5hk5ohMD_-xsomZs-VbJcyGs0uzn-y1vvzhhl22iUKuzj_QUdnyTyz7UM42Nne38rDNilDOMHzDsWZWM5tikCCcxGXkbQIOG0cKxfZymaZzeJCFZKrzHEVo63rhBWFEqIUqoyKJHkEq_W0dmvAYovwSzg02azjhTK2Es5WcYIdpZImDeCVF44-bYg3tDk7oji0VOiPo139aZD3--O9Q50HsHFFel2HOJUq7WU8gPWlOHWrozMdkY-TalUAL7pq1C5ymZjaTRfYhido85HNGsDjZhlcDp6gaZtIEcBrL8yuYmlXoRS1l6Le2h75wpN_b_ocbub7w4EevB99eAq3YsrC4WMI12F1frZwzxALze2GX_K_APP9A7U
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceD8CpRgJIS6pEsd2YjihtttlaVeoomWFkCzbcaRVS3bV3RWPU38CV_5efwljJ5tSxAFxs-Q4SvzN2N94xjMAz4xNeCkTHVfIRWPmchGbNLdxgSuh1nmZJsafd-wPRf-QDUZ8tAKvlndhmvwQ3YGb14ywXnsFn5bVb0puXe1TIxT8ClxlIim8SG8fXOSO4u1d6cxfnRaCtWmFfBhPNxQZqZ_Mrz4iUs9wUqqmmsXf6OZl9hq2n94N-LT88Cbq5HhzMTeb9vsfOR3_889uwvWWlpLXjRzdghVX34a1_dbxfgeOcE1ZfCa-NFM9xsZ4Rk4mX8i4JkjLT76RsonYcyXZ9fWMZudnP0nr-3lJNJl2ZcLOz374jbMkIa_tXTjs7bzf6sdtSYZ4jLsdgpkZxkyONIIxTstUGKSbhlLpUlOZojAFtdIKJgvHJEVL13HDreS85LJMbZbdg9V6UrsHQKhB8sUdGmzGMSu1qbgzFc1woJBC5xE8D9ioaZN2Q-nTYx-FlnP1YbirPu71B4PRwZHqR7BxCbxuAM2FzJOCRbC-RFO1GjpTqfdw-l4ZwdOuG3XLO0x07SYLfIZlaPF5izWC-40UXLw8Q8M2EzyCFwHLrmNpVSGKKqCotnaGofHw3x99Amvvtntq783w7SO4Rn0JjhBAuA6r89OFe4xEaG42gsD_AgegAm0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+selenium+is+low+in+newly+diagnosed+Graves%27+disease%3A+a+population-based+study&rft.jtitle=Clinical+endocrinology+%28Oxford%29&rft.au=B%C3%BClow+Pedersen%2C+Inge&rft.au=Knudsen%2C+Nils&rft.au=Carl%C3%A9%2C+Allan&rft.au=Schomburg%2C+Lutz&rft.date=2013-10-01&rft.eissn=1365-2265&rft.volume=79&rft.issue=4&rft.spage=584&rft_id=info:doi/10.1111%2Fcen.12185&rft_id=info%3Apmid%2F23448365&rft.externalDocID=23448365
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0664&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0664&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0664&client=summon